Predicting the Safety and Effectiveness of Inferior Vena Cava Filters (PRESERVE): Outcomes at 12 months

Johnson, Matthew S.; Spies, James B.; Scott, Katherine T.; Kato, Bernet S.; Mu, Xiangyu; Rectenwald, John E.; White, Rodney A.; Lewandowski, Robert J.; Khaja, Minhaj S.; Zuckerman, Darryl A.; Casciani, Thomas; Gillespie, David L.

doi:10.1016/j.jvsv.2022.11.002

Cited by 13 publications

(10 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Retrievable filters possess tethering hooks for anchoring, like many permanent devices, but also possess a hook for later retrieval [ 10 , 11 ]. The filters used in the PRESERVE trial were ALN (ALN ± hook), Argon (Option Elite), B. Braun (LP, VenaTech Convertible), CR Bard (Denali), Cook (Gunther Tulip), Cordis (OptEase, TrapEase), and Philips Volcano (Crux) [ 14 ]. Figure 1 depicts some of the different types of IVC filters.…”

Section: Historical Overview and Currently Available Ivc Filtersmentioning

confidence: 99%

“…In the ICOPER, none of the 11 (10.1%) patients who received an IVC filter developed recurrent PE within 90 days, and 10 (90.9%) survived at least 90 days. They showed that IVC filters were associated with a reduction in 90-day mortality (hazard ratio, 0.12; 95% CI, 0.02 to 0.85) [ 14 ]. In EMPEROR, 9 out of 58 patients with massive PE (defined as SBP < 90 mm Hg) received IVC filters, and 273 out of 1817 patients with non-massive PE (defined as SBP ≥ 90 mm Hg) received IVC filters.…”

Section: The Evolution In the Role Of Ivc Filters In The Management O...mentioning

confidence: 99%

“…Reports from both the EMPEROR registry and ICOPER indicated low rates of systemic thrombolysis administration in patients with high-risk PE. In ICOPER, 33 patients (30.5%) underwent thrombolysis, 1 (0.9%) underwent catheter-directed therapy, and 3 (2.7%) had surgical embolectomy [ 14 ]. In EMPEROR, 7 patients (12.1%) underwent thrombolysis, none underwent catheter-directed therapy, and 2 (3.4%) had surgical embolectomy [ 16 ].…”

Section: The Evolution In the Role Of Ivc Filters In The Management O...mentioning

confidence: 99%

“…In early generation retrievable IVC filters, some devices had recommendations about the window of opportunity for removal, but current generation devices and even many early generation IVC filters can now be safely removed with interventional radiology techniques [ 12 , 13 ]. Importantly, Johnson et al’s findings from The Predicting the Safety and Effectiveness of IVC Filters (PRESERVE) trial showed that while IVC filter complications do occur, those that are clinically significant are rare with currently available filters [ 14 ]. While both appropriate and inappropriate IVC filter use are associated with risk, a role remains for IVC filter use in select patients with PE.…”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

The Role of IVC Filters in the Management of Acute Pulmonary Embolism

Asmar,

Michael,

Gallo

et al. 2024

JCM

View full text Add to dashboard Cite

Venous thromboembolism (VTE), comprising deep venous thrombosis (DVT) and pulmonary embolism (PE), is a prevalent cardiovascular condition, ranking third globally after myocardial infarction and stroke. The risk of VTE rises with age, posing a growing concern in aging populations. Acute PE, with its high morbidity and mortality, emphasizes the need for early diagnosis and intervention. This review explores prognostic factors for acute PE, categorizing it into low-risk, intermediate-risk, and high-risk based on hemodynamic stability and right ventricular strain. Timely classification is crucial for triage and treatment decisions. In the contemporary landscape, low-risk PE patients are often treated with Direct Oral Anticoagulants (DOACS) and rapidly discharged for outpatient follow-up. Intermediate- and high-risk patients may require advanced therapies, such as systemic thrombolysis, catheter-directed thrombolysis, mechanical thrombectomy, and IVC filter placement. The latter, particularly IVC filters, has witnessed increased usage, with evolving types like retrievable and convertible filters. However, concerns arise regarding complications and the need for timely retrieval. This review delves into the role of IVC filters in acute PE management, addressing their indications, types, complications, and retrieval considerations. The ongoing debate surrounding IVC filter use, especially in patients with less conventional indications, reflects the need for further research and data. Despite complications, recent studies suggest that clinically significant issues are rare, sparking discussions on the appropriate and safe utilization of IVC filters in select PE cases. The review concludes by highlighting current trends, gaps in knowledge, and potential avenues for advancing the role of IVC filters in future acute PE management.

show abstract

Section: Historical Overview and Currently Available Ivc Filtersmentioning

confidence: 99%

Section: The Evolution In the Role Of Ivc Filters In The Management O...mentioning

confidence: 99%

Section: The Evolution In the Role Of Ivc Filters In The Management O...mentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

The Role of IVC Filters in the Management of Acute Pulmonary Embolism

Asmar,

Michael,

Gallo

et al. 2024

JCM

View full text Add to dashboard Cite

show abstract

“… 10 - 12 Since retrievable filters were introduced several decades ago, their current removal rate is not high enough, estimated from 34% to 45%. 13 , 14 Thus, a lot of patients require anticoagulation in the presence of IVC filter, which raised concern about the reliability of direct oral anticoagulants (DOACs) in such circumstances. Although phase III trials showed similar efficacy and improved safety of DOACs in comparison with vitamin K antagonists (VKAs) in patients with DVT and PE, the evidence on their use after IVC filter implantation is still limited.…”

Section: Introductionmentioning

confidence: 99%

Oral Rivaroxaban Versus Warfarin After inferior Vena cava Filter Implantation: A Retrospective Cohort Study

Schastlivtsev,

Pankov,

Tsaplin

et al. 2024

Clin Appl Thromb Hemost

View full text Add to dashboard Cite

Objectives To assess the efficacy and safety of rivaroxaban compared to warfarin after inferior vena cava (IVC) filter implantation. Method This retrospective analysis includes data from 100 patients with deep vein thrombosis (DVT) who underwent IVC filter implantation due to a free-floating thrombus (n = 64), thrombus propagation (n = 8), or acute bleeding (n = 8) on therapeutic anticoagulation, catheter-directed thrombolysis (n = 8), or had previously implanted filter with DVT recurrence. Patients were treated with warfarin (n = 41) or rivaroxaban (n = 59) for 3-12 months. Symptomatic venous thromboembolism (VTE) recurrence and bleeding events were assessed at 12 months follow-up. Results Three (7.3%) cases of VTE recurrence without IVC filter occlusion occurred on warfarin and none on rivaroxaban. The only (2.4%) major bleeding occurred on warfarin. Three (5.1%) clinically relevant non-major bleedings were detected on rivaroxaban. No significant differences existed between groups when full and propensity scores matched datasets were compared. Conclusions Rivaroxaban seems not less effective and safe than warfarin after IVC filter implantation.

show abstract

Inferior vena cava filter misplacement with SVC perforation

Rodríguez

Lopera

2023

Journal of Interventional Medicine

View full text Add to dashboard Cite

Predicting the Safety and Effectiveness of Inferior Vena Cava Filters (PRESERVE): Outcomes at 12 months

Cited by 13 publications

References 17 publications

The Role of IVC Filters in the Management of Acute Pulmonary Embolism

The Role of IVC Filters in the Management of Acute Pulmonary Embolism

Oral Rivaroxaban Versus Warfarin After inferior Vena cava Filter Implantation: A Retrospective Cohort Study

Inferior vena cava filter misplacement with SVC perforation

Contact Info

Product

Resources

About